|
WO2015104030A1
|
|
Pharmaceutical compositions comprising imiquimod for use in the treatment of carcinoma in situ of the bladder
|
|
CA2881863A1
|
|
Phospholipid drug analogs
|
|
WO2015036044A1
|
|
Cationic lipid vehicles for delivery of tlr7 agonists for specific targeting of human cd14+ monocytes in whole blood
|
|
US2013273144A1
|
|
Phospholipid drug analogs
|
|
WO2012038058A1
|
|
Treatment of conditions by toll-like receptor modulators
|
|
KR20130056249A
|
|
Phospholipid drug analogs
|
|
WO2011134669A1
|
|
Methods for inducing an immune response
|
|
WO2010088924A1
|
|
Pharmaceutical compositions comprising imidazoquinolin(amines) and derivatives thereof suitable for local administration
|
|
AU2009210655A1
|
|
Treatment of bladder diseases with a TLR7 activator
|
